Our researchers are discovering new vaccines and prevention strategies against infectious diseases
![NYBCe research scientist Asim Debnath](https://zq04yxwd3kp9n66tnv.blob.core.windows.net/storage-wordpress-web-production/2024/02/Asim-debnath.jpg)
Asim K Debnath, PhD
Head, Laboratory of Molecular Modeling and Drug Design
• Research focuses on identifying new antiviral drugs by state-of-the art drug design methods
• Ongoing projects include identifying small molecule entry inhibitors for HIV and COVID-19 to prevent the viruses from entering cells
![Cheryl Lobo, PhD
Head, Laboratory of Blood-Borne Parasites, NYBCe](https://zq04yxwd3kp9n66tnv.blob.core.windows.net/storage-wordpress-web-production/2024/02/lobo.png)
Cheryl Lobo, PhD
Head, Laboratory of Blood-Borne Parasites
• Studies on mechanisms of cell entry by Malaria and Babesia, which can be transmitted by transfusion
• Research on developing viable interventions, including drugs, to halt transmission of these pathogens
![](https://zq04yxwd3kp9n66tnv.blob.core.windows.net/storage-wordpress-web-production/2024/02/lustigman.jpg)
Sara Lustigman
Head, Laboratory of Molecular Parasitology
• Research into river blindness and elephantiasis with goal of developing treatment or vaccines
• Developed adjuvant that enhances vaccine efficacy for a variety of infectious diseases